PATENT CLAIM ANALYSIS

Application Number: 15999239
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-04
Patent Classification: ["424", "085400"]

Abstract:
Methods of treating a hepatitis delta virus (HDV) infection in a human patient are provided. In some embodiments, the method comprising administering to the patient a therapeutically effective amount of interferon lambda for at least four weeks.

Claim (Index 22):
The method of any of  claims 1  to  21 , wherein the method further comprises administering to the patient another antiviral or anti-HDV agent.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 96.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15335327', '13875253', '13119760', '15408087', '14449174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7414273099638684
- 35 USC 102 Novelty (BERT): 0.5377992047762551
- Combined Prediction Score: 0.7210644994451071
- Mean Citation Score: 274.69786200000004
- Max Citation Score: 376.35223
- Similarity Product: 291.2714976705521

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test